Literature DB >> 32454677

The Effect of Sumatriptan in Ischemic Conditions in the Rat Heart.

Hande Özge Altunkaynak-Çamca1, Müge Tecder-Ünal1, Meral Tuncer1.   

Abstract

OBJECTIVES: The aim of this study was to investigate the effect of SUM on IR-induced injury in rat heart and its effect on IPC-induced protection.
MATERIALS AND METHODS: The rats were randomly divided into four groups: IR, SUM-IR, IPC, and SUM-IPC. The mean arterial blood pressure and heart rate were recorded to calculate PRP. Standard limb lead 2 ECG were recorded to evaluate arrhythmia parameters.
RESULTS: The PRP values in the SUM-IPC group were significantly lower than in the SUM-IR group at the beginning of reperfusion (p<0.05). The incidence of VT in the IPC, SUM-IR, and SUM-IPC groups was significantly lower than in the IR group (p<0.05). VF was only observed in the IR group.
CONCLUSION: SUM protects the heart against IR injury but is not as protective as IPC alone. Although SUM diminishes IPC-induced protection against VT, the preventive effect of SUM against VF may be predictive for cardioprotection in ischemic conditions. ©Copyright 2018 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Sumatriptan; arrhythmia; heart; ischemia and reperfusion; ischemic preconditioning

Year:  2018        PMID: 32454677      PMCID: PMC7227824          DOI: 10.4274/tjps.03371

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  24 in total

1.  Differential action of two prolactin isoforms on ischemia and re-perfusion-induced arrhythmias in rats in vivo.

Authors:  T F Krzeminski; K Mitrega; M Porc; M Zorniak; F Ryszka; Z Ostrowska; B Kos-Kudła
Journal:  J Endocrinol Invest       Date:  2010-10-04       Impact factor: 4.256

2.  Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.

Authors:  Christopher M H Newman; Ian Starkey; Nigel Buller; Ricardo Seabra-Gomes; Simon Kirby; Jayasena Hettiarachchi; David Cumberland; William S Hillis
Journal:  Eur J Clin Pharmacol       Date:  2005-09-08       Impact factor: 2.953

Review 3.  Physiology and pharmacology of myocardial preconditioning and postconditioning.

Authors:  Julie Huffmyer; Jacob Raphael
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2009-03-26

4.  A study of the effects of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH3 positron emission tomography.

Authors:  P J Lewis; S F Barrington; P K Marsden; M N Maisey; L D Lewis
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

5.  Comparative study of the cardioprotective effects of local and remote preconditioning in ischemia/reperfusion injury.

Authors:  Lamiaa A Ahmed; Hesham A Salem; Amina S Attia; Azza M Agha
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

6.  Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

Authors:  C Duquesnoy; J P Mamet; D Sumner; E Fuseau
Journal:  Eur J Pharm Sci       Date:  1998-04       Impact factor: 4.384

Review 7.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

8.  Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.

Authors:  P D MacIntyre; B Bhargava; K J Hogg; J D Gemmill; W S Hillis
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

9.  Simultaneous measurement of plasma protein extravasation and carotid vascular resistance in the rat.

Authors:  R A Spokes; V C Middlefell
Journal:  Eur J Pharmacol       Date:  1995-07-25       Impact factor: 4.432

10.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

Authors:  M J Walker; M J Curtis; D J Hearse; R W Campbell; M J Janse; D M Yellon; S M Cobbe; S J Coker; J B Harness; D W Harron
Journal:  Cardiovasc Res       Date:  1988-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.